# Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

> **NCT03764228** · NA · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 27 (estimated)

## Conditions studied

- Acute-graft-versus-host Disease

## Interventions

- **BIOLOGICAL:** hAECs

## Key facts

- **NCT ID:** NCT03764228
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03764228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03764228, "Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03764228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*